Menu UF Health Home Menu
1st Place: Kelsey Kite

Looking back on Diabetes Awareness Month

During the month of November, UF and UF Health celebrated Diabetes Awareness Month with events to help support patients and research at UF Health.

Thank you for going blue!


Excellence in one place

At the University of Florida, we provide complete care for children and adults with diabetes. For our patients’ convenience, all our services are under one roof. Learn about our approach to comprehensive patient care.

New appointments: 1.855.UF.DIABETES (483.3422)


Progress in sight

A new vision research facility is set to open at the University of Florida in 2015 that will be used to advance early detection and treatment options for eye-related complications, including diabetic retinopathy – the leading cause of adult blindness in the United States.


Stronger. Together.

The University of Florida and the American Diabetes Association are working together in efforts to improve the lives of all those impacted by diabetes and to pioneer strategies to prevent and reverse the disease. From innovative research to year-round advocacy, learn about the progress we are making as national leaders.

Collage 4

Meet Our Team

The UF Diabetes Institute research team is collectively one of the most comprehensive in the United States. Numerous faculty members from multiple colleges and disciplines are working together in this area which is rapidly changing our understanding of disease progression and treatment.

Prev Next

Recent NewsSubscribe to RSS Feed


Unlocking a combo therapy for new onset T1D, new trial announced

A new trial will determine whether a novel combination drug therapy works to reverse Type 1 diabetes in humans, building on UF findings reported earlier this year. UF Health pediatric endocrinologist Michael Haller, M.D., will serve as principal investigator for the new study. "Currently, there are no sufficient drug treatment options available that target diabetes in this way," Haller said. “If effective, it would inevitably lead to larger clinical studies and prevention aims.”


UF T1D research among JDRF’s Top 10 Research Advances in 2014

A collaborative Type 1 diabetes study led by researchers from UF and the Institute of Diabetes Research, Helmholtz Zentrum Munchen, in Germany was recently recognized among JDRF's Top 10 Research Advances in 2014. Bacterial interactions within the gut may influence T1D – building on the microbiome theory. Learn more.


U.S. diabetes care costs soar, new study finds

A study in the December issue of Diabetes Care found health and other costs associated with diabetes care grew 48% in recent years, to $322 billion yearly. In 2012, excess medical costs and lost productivity associated with diabetes totaled more than $1,000 for every American. That total includes $244 billion in medical costs -- including doctor's office and hospital visits, prescription drugs and other health conditions such as high blood pressure and kidney complications -- and $78 billion in lost work productivity.


New research study examines complications in type 1 diabetes

Individuals with type 1 diabetes have a ten-times higher risk for cardiovascular events than age-matched non-diabetic populations. Researchers in the UF Department of Pediatrics are recruiting for a new, non-invasive study that will measure arterial stiffness in children. Long-term increases in the stiffness of blood vessels may increase the risk of heart attack and stroke. For more information, contact

Head Shot (2)

UF Diabetes Expert Speaks at National Continuing Education Conference

Ashby Walker, Ph.D., research assistant professor in the Department of Health Outcomes and Policy, recently presented at a national conference for nurse educators and physicians in Tampa, Fla., to discuss a recent UF photo research project, in which children with Type 1 diabetes were prompted to take and explain five pictures that captured what diabetes meant to them. The photos and explanations provide valuable perspectives and highlight the differences in disease experiences based on gender and socioeconomic status.


Processing sugar: Could artificial sweeteners promote diabetes?

Over the past decade, increased consumption of table sugar and artificial sweeteners have been linked to rising rates of obesity and Type 2 diabetes in the United States and throughout the world. Now, new research evidence builds on these previous findings, providing new insights into pathogenesis and innovative therapies for this important disease. Read more.

Upcoming Events


Take Charge of Diabetes: Suwannee County

From 9:00am until 11:00am

Sponsors & Collaborators